Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Parspour, M. Metintas, G. Ak, H. Yildirim, E. Dundar (Eskisehir, Turkey). Is prophylactic radiotherapy at intervention site always neccessary in malign pleural mesothelioma?. Eur Respir J 2006; 28: Suppl. 50, 4306

Member's Comments

No comment yet.

Related content which might interest you: Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Role of surgery and of radiotherapy in malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource Source: Eur Respir J 2007; 30: 1021 Year: 2007 Multimodality therapy for malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 Are patients with malignant pleural effusions being referred appropriately for surgical intervention? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017 Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience Source: International Congress 2017 – General thoracic surgery Year: 2017 Three dimensional evaluation of chemotherapy response in malign pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 754s Year: 2007 Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003 Systemic therapy 1 in malignant pleural mesothelioma: chemotherapy Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005 Multimodal management of malignant pleural mesothelioma: where are we today? Source: Eur Respir J 2014; 44: 754-764 Year: 2014 Thoracoscopic palliative treatment of malignant pleural effusions Source: Annual Congress 2011 - A little bit of everything: interventional pneumology Year: 2011 Multimodality treatment of malignant pleural mesothelioma Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma Year: 2011 Surgery and multimodality treatment for malignant pleural mesothelioma Source: Eur Respir Mon; 2009: 44: 407–418 Year: 2009 Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2003; 22: Suppl. 45, 509s Year: 2003 Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009